Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation

Completed

• Conditions: Metabolic Disorders

• Registration Number: NCT02311270
• Lead Sponsor: University of South Florida

Brief Summary

The purpose of this study is to learn about the effects of long term carnitine use in patients with metabolic disorders and its potential relationship to cardiovascular events.

Detailed Description

This online cross-sectional survey will examine the self-reported long-term carnitine use in patients with metabolic disorders and any potential relationship to cardiovascular events.

Study Timeline

• Study Start: 2014-09
• Study First Submitted: 2014-09-12
• Study First Submitted QC: 2014-12-04
• Study First Posted: 2014-12-08
• Primary Completion: 2015-09
• Study Completion: 2016-06
• Status Verified: 2016-09
• Last Update Submitted: 2016-09-22
• Last Update Posted: 2016-09-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 106

Inclusion Criteria

• Diagnosis of mitochondrial disease or any other metabolic disorder
• Any age group
• NAMDC or RDCRN registry participant

Exclusion Criteria

• Inability to provide informed consent and complete survey
• Lack of participation in NAMDC or RDCRN registry

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assess how many patients with metabolic disorders are on chronic carnitine supplementation.	Up to one year from study activation.

Secondary Outcome Measures

Name	Time	Method
Assess how many patients who are on chronic carnitine supplementation have experienced a cardiovascular event.	Up to one year from study activation

Trial Locations

Locations (1)

University of South Florida; 🇺🇸 Tampa, Florida, United States